(-0.88%) 4 967.23 points
(0.56%) 37 986 points
(-2.05%) 15 282 points
(0.74%) $83.34
(0.34%) $1.763
(0.20%) $2 402.90
(1.11%) $28.70
(-1.15%) $943.50
(-0.14%) $0.938
(-0.24%) $11.02
(0.54%) $0.808
(-0.94%) $93.01
Live Chart Being Loaded With Signals
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, and sale of single-use medical devices in the People's Republic of China...
Stats | |
---|---|
Today's Volume | 8.78M |
Average Volume | 9.64M |
Market Cap | 21.53B |
EPS | HKD0 ( 2024-03-25 ) |
Last Dividend | HKD0.0870 ( 2023-06-01 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 9.92 |
ATR14 | HKD0.00500 (0.11%) |
Volume Correlation
Shandong Weigao Group Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Shandong Weigao Group Correlation - Currency/Commodity
Shandong Weigao Group Financials
Annual | 2022 |
Revenue: | HKD13.62B |
Gross Profit: | HKD7.11B (52.23 %) |
EPS: | HKD0.600 |
Q2 | 2023 |
Revenue: | HKD3.45B |
Gross Profit: | HKD1.77B (51.37 %) |
EPS: | HKD0.130 |
Q1 | 2023 |
Revenue: | HKD3.45B |
Gross Profit: | HKD1.77B (51.37 %) |
EPS: | HKD0.130 |
Q4 | 2022 |
Revenue: | HKD3.32B |
Gross Profit: | HKD1.78B (53.70 %) |
EPS: | HKD0.140 |
Financial Reports:
No articles found.
Shandong Weigao Group Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0.0960 (N/A) |
HKD0 (N/A) |
HKD0.0870 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.00175 | 2004-09-02 |
Last Dividend | HKD0.0870 | 2023-06-01 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 39 | -- |
Total Paid Out | HKD1.546 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.78 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 5.37 | |
Div. Directional Score | 7.98 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
6862.HK | Ex Dividend Knight | 2023-06-09 | Annually | 0 | 0.00% | |
1972.HK | Ex Dividend Knight | 2023-09-06 | Semi-Annually | 0 | 0.00% | |
1001.HK | Ex Dividend Junior | 2023-08-24 | Annually | 0 | 0.00% | |
0114.HK | Ex Dividend Knight | 2023-10-03 | Annually | 0 | 0.00% | |
3339.HK | Ex Dividend Knight | 2023-05-30 | Annually | 0 | 0.00% | |
1579.HK | Ex Dividend Knight | 2023-05-22 | Annually | 0 | 0.00% | |
0609.HK | Ex Dividend Knight | 2023-10-03 | Annually | 0 | 0.00% | |
9869.HK | No Dividend Player | 2023-09-19 | Insufficient data to determine frequency | 0 | 0.00% | |
2156.HK | Ex Dividend Knight | 2023-06-01 | Annually | 0 | 0.00% | |
1157.HK | Ex Dividend Junior | 2023-07-03 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.179 | 1.500 | 6.42 | 9.63 | [0 - 0.5] |
returnOnAssetsTTM | 0.0539 | 1.200 | 8.20 | 9.84 | [0 - 0.3] |
returnOnEquityTTM | 0.0835 | 1.500 | -0.183 | -0.275 | [0.1 - 1] |
payoutRatioTTM | 0.203 | -1.000 | 7.97 | -7.97 | [0 - 1] |
currentRatioTTM | 2.84 | 0.800 | 0.802 | 0.641 | [1 - 3] |
quickRatioTTM | 2.10 | 0.800 | 2.35 | 1.879 | [0.8 - 2.5] |
cashRatioTTM | 0.993 | 1.500 | 5.60 | 8.39 | [0.2 - 2] |
debtRatioTTM | 0.128 | -1.500 | 7.87 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 7.19 | 1.000 | 8.45 | 8.45 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.377 | 2.00 | 9.87 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.259 | 2.00 | 9.87 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.197 | -1.500 | 9.21 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.521 | 1.000 | 4.65 | 4.65 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.205 | 1.000 | 7.91 | 7.91 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.392 | 1.000 | 8.93 | 8.93 | [0.2 - 2] |
assetTurnoverTTM | 0.301 | 0.800 | -1.326 | -1.061 | [0.5 - 2] |
Total Score | 10.60 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 10.38 | 1.000 | 9.05 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0835 | 2.50 | -0.118 | -0.275 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.259 | 2.00 | 9.91 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 3.96 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.377 | 2.00 | 9.87 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.203 | 1.500 | 7.97 | -7.97 | [0 - 1] |
pegRatioTTM | 0.159 | 1.500 | -2.28 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.167 | 1.000 | 8.34 | 0 | [0.1 - 0.5] |
Total Score | 5.37 |
Shandong Weigao Group
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, and sale of single-use medical devices in the People's Republic of China. It operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments. The company offers vascular and non-vascular access infusion devices, infusion sets, syringes, puncture needles, and specialized single-use clinical collection kits; wound sutures, wound healing dressings, and wound cleaning and nonvascular catheter supporting extracorporeal devices; and blood collection, storage, separation, and sterilization equipment. It also provides prefilled syringes and pre-filled flush syringes; blood collection and blood glucose testing devices; and general anesthesia consumables, local anesthesia consumables, anesthesia auxiliary consumables, ICU equipment, and open and minimally invasive surgical equipment. In addition, the company engages in the production and sale of orthopedic devices; tumor and blood vessel interventional instruments; implantation materials and artificial organs; medical PVC granules, plastic packing bags, and carton boxes; industrial automatic equipment and parts; molds; hemodialysis equipment; and type I, type II, and type III medical devices. Further, it is involved in the finance leasing and factoring business; wholesale of type I medical devices, surgical devices, and other disposal medical products; provision of asset management, enterprise consulting, enterprise management advisory services, as well as logistics and storage services, as well as export its products. The company offers its products under the Jierui, Wego Ortho, Yahua, Bangde, and Hai Xing brands. It serves hospitals, blood stations, and other medical units; and distributors. The company was incorporated in 2000 and is based in Weihai, the People's Republic of China.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators